Temiverine Hydrochloride Hydrate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTemiverine Hydrochloride Hydrate
Drug Alias Nametemiverina盐酸替米维林水合物temiverinum替米维林盐酸盐水合物Urespan +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersMuscarinic acetylcholine receptor M3 antagonists
TargetsVoltage-gated calcium channelMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Shinyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Shinyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksKEGG